A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-4597 Inhalation in Healthy Subjects and Asthmatic Patients
Clinical trial NCT06385964 · COMPLETED
Trial details
- NCT number
- NCT06385964
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-07
- Primary completion
- 2025-02-19
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.